Patent application number | Description | Published |
20160078289 | Gesture Recognition Apparatuses, Methods and Systems for Human-Machine Interaction - The GESTURE RECOGNITION APPARATUSES, METHODS AND SYSTEMS FOR HUMAN-MACHINE INTERACTION (“GRA”) discloses vision-based gesture recognition. GRA can be implemented in any application involving tracking, detection and/or recognition of gestures or motion in general. Disclosed methods and systems consider a gestural vocabulary of a predefined number of user specified static and/or dynamic hand gestures that are mapped with a database to convey messages. In one implementation, the disclosed systems and methods support gesture recognition by detecting and tracking body parts, such as arms, hands and fingers, and by performing spatio-temporal segmentation and recognition of the set of predefined gestures, based on data acquired by an RGBD sensor. In one implementation, a model of the hand is employed to detect hand and finger candidates. At a higher level, hand posture models are defined and serve as building blocks to recognize gestures | 03-17-2016 |
20160086350 | APPARATUSES, METHODS AND SYSTEMS FOR RECOVERING A 3-DIMENSIONAL SKELETAL MODEL OF THE HUMAN BODY - The ARS offers tracking, estimation of position, orientation and full articulation of the human body from marker-less visual observations obtained by a camera, for example an RGBD camera. An ARS may provide hypotheses of the 3D configuration of body parts or the entire body from a single depth frame. The ARS may also propagates estimations of the 3D configuration of body parts and the body by mapping or comparing data from the previous frame and the current frame. The ARS may further compare the estimations and the hypotheses to provide a solution for the current frame. An ARS may select, merge, refine, and/or otherwise combine data from the estimations and the hypotheses to provide a final estimation corresponding to the 3D skeletal data and may apply the final estimation data to capture parameters associated with a moving or still body. | 03-24-2016 |
Patent application number | Description | Published |
20140251900 | INHIBITION OF METHANE PRODUCTION DURING ANAEROBIC REDUCTIVE DECHLORINATION - This method of restricting methane production in methanogenic bacteria, by the use of the enzyme and coenzyme inhibitors, works during anaerobic reductive dechlorination. Various compounds such as, but not limited to, red yeast rice, vitamin B10 derivatives, and ethanesulfonates are utilized to disrupt these different enzyme and coenzyme systems responsible for the production of methane. This method affects the competition of the methanogen and halo bacteria for the organic hydrogen donors that are injected in the soil and groundwater system during the remediation process. | 09-11-2014 |
20140311971 | USE OF ENCAPSULATED SUBSTRATES THAT CONTROLTHE RELEASE RATES OF ORGANIC HYDROGEN DONORS - Anaerobic reductive dechlorination processes remove chlorinated solvents from contaminated subsurface soil and ground water. The presence of organic hydrogen donors enables anaerobic microorganisms present in the subsurface soil and groundwater to accelerate the reductive dechlorination process. The present invention provides an alternative method to control the release rate of organic hydrogen donors during dechlorination. The invention utilizes encapsulated substrates to control the release rate of organic hydrogen donors, therefore accelerating the biotic process of anaerobic reductive dechlorination. | 10-23-2014 |
20140322798 | INHIBITION OF METHANE PRODUCTION DURING ANAEROBIC REDUCTIVE DECHLORINATION - This method of restricting methane production in methanogenic bacteria, by the use of the enzyme and coenzyme inhibitors, works during anaerobic reductive dechlorination. Various compounds such as, but not limited to, red yeast rice, vitamin B10 derivatives, and ethanesulfonates are utilized to disrupt these different enzyme and coenzyme systems responsible for the production of methane. This method affects the competition of the methanogen and halo bacteria for the organic hydrogen donors that are injected in the soil and groundwater system during the remediation process. | 10-30-2014 |
20140335601 | CHEMICAL OXIDATION AND BIOLOGICAL ATTENUATION PROCESS FOR THE TREATMENT OF CONTAMINATED MEDIA - A method for the removal of semi-volatile organic compounds in soils, sludges, groundwater, process water, and wastewater is presented. Oxidation and biological attenuation processes utilize persulfates and other oxidants with trivalent metals, such as ferrous iron or Mn | 11-13-2014 |
20140335602 | CHEMICAL OXIDATION AND BIOLOGICAL ATTENUATION PROCESS FOR THE TREATMENT OF CONTAMINATED MEDIA - A method for the removal of semi-volatile organic compounds in soils, sludges, groundwater, process water, and wastewater is presented. Oxidation and biological attenuation processes utilize peroxide, persulfates, percarbonates, and/or other oxidants with trivalent metals, such as ferric iron (Fe3+) or manganic ion (Mn | 11-13-2014 |
20150183670 | HEAVY METAL STABILIZATION AND METHANE INHIBITION DURING INDUCED OR NATURALLY OCCURRING REDUCING CONDITIONS IN CONTAMINATED MEDIA - A method for inhibiting methane production in naturally occurring or induced reducing conditions, thus subsequently resulting into inhibition of the biomethylation process of the heavy metals is disclosed. The disclosed inhibiting composition blocks 3-hydroxy-3-ethylglutaryl coenzyme A (HMG-CoA) reductase, and 8-hydroxy-5-deazaflavin (coenzyme F | 07-02-2015 |
20160076057 | INHIBITION OF METHANE AND HYDROGEN SULFIDE PRODUCTION IN ANAEROBIC DIGESTER ANIMAL FARMS, LANDFILLS, SEDIMENTS AND SEWER SYSTEMS - A method for inhibiting methane and hydrogen sulfide production from anaerobic digester systems and other biogas generating mediums disclosed. The biogas generating medium is contacted with an effective amount of a composition comprising red yeast rice and iron oxide to cause inhibition of methane and hydrogen sulfide production, and is useful in biogas generating medium from animal farms, including a swine, cattle or chicken farms. The method is useful to inhibit methane and hydrogen sulfide production in sewage systems, landfills, and sediment containing organic carbon. The disclosed inhibiting composition blocks 3-hydroxy-3-ethylglutaryl coenzyme A (HMG-CoA) reductase, and 8-hydroxy-5-deazaflavin (coenzyme F | 03-17-2016 |
Patent application number | Description | Published |
20100261776 | BRUTON'S TYROSINE KINASE AS ANTI-CANCER DRUG TARGET - Receptor protein tyrosine kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating the formation of complexes that regulate key cellular functions. Over half of the 90 tyrosine kinases have been implicated in human cancers and are for this reason considered highly promising drug targets. To gain insight into the tyrosine kinases that contribute to breast cancer related cellular mechanisms, we carried out a large-scale loss-of-function analysis of the tyrosine kinases, using RNA interference, in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line. The cytosolic, non-receptor tyrosine kinase Bruton's tyrosine kinase (BTK), which has been extensively studied for its role in B cell development, was among those tyrosine kinase genes required for BT474 breast cancer cell survival. The BTK protein identified was an alternative form containing an amino-terminal extension. This alternative form of the Btk message is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells. | 10-14-2010 |
20100267803 | Regulators Of Fat Metabolism As Anti-Cancer Targets - Embodiments of the invention provide methods of identifying agents that reduce or prevent the proliferation of breast cancer cells, or kill them, in particular by interfering with the expression of the transcription factors NR1D1 and PPARγ or the expression of genes whose transcription they activate or the activity of the proteins translated from those transcripts. | 10-21-2010 |
20120165395 | Bruton's Tyrosine Kinase As Anti-Cancer Drug Target - Receptor protein tyrosine kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of the tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer cell survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells. | 06-28-2012 |
20140073593 | BRUTON'S TYROSINE KINASE AS ANTI-CANCER DRUG TARGET - Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells. | 03-13-2014 |
20140288098 | Bruton's Tyrosine Kinase As Anti-Cancer Drug Target - Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells. | 09-25-2014 |
20160053024 | Bruton's Tyrosine Kinase As Anti-Cancer Drug Target - Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells. | 02-25-2016 |
Patent application number | Description | Published |
20140117912 | System For Detecting Internal Winding Faults Of A Synchronous Generator, Computer Program Product And Method - A system, method and computer program product for monitoring including detecting internal faults especially inter-turn faults of a synchronous generator and thus protecting the synchronous generator. The synchronous generator includes a winding for each phase of a power network, a terminal for each phase arranged on a terminal side of the synchronous generator, and connected to the respective winding, the terminals on the terminal side are connected to an electrical power network, and the synchronous generator is arranged to input power to the electrical power network by means of the terminals. | 05-01-2014 |
20140336833 | Wind Park With Real Time Wind Speed Measurements - A system for producing electrical power based on wind energy is capable of predicting its power output. The system includes a set of wind turbine units, a first plurality of sensors each adapted to sense at least one wind characteristic at some of the wind turbine units, and a second plurality of sensors remotely located. At least one wind characteristic is estimated at the wind turbines not having one of the first plurality of sensors based on sensing by the first plurality of sensors and an estimate of changes in wind characteristic at wind turbine units caused by presence of other wind turbine units. The magnitude of electrical power production by the set of wind turbine units at at least one predefined point in time in the future is predicted based on the estimated wind characteristics and sensed wind characteristics. | 11-13-2014 |
20150115721 | POWER SYSTEM AND METHOD OF OPERATING A POWER SYSTEM - A power system includes a power generating plant including a plurality of power generators, and an AC collection grid adapted to interconnect the power generating plant and an HVDC converter station. The AC collection grid is adapted to operate outside network regulations, whereby advantages such as simplified control and electronics are achieved. A method of operating a power system is also provided. | 04-30-2015 |
20150372490 | Method of Controlling a Solar Power Plant, A Power Conversion System, a DC/AC Inverter and a Solar Power Plant - A solar power plant including a power conversion system and a method of controlling the power conversion system. Implemented in a DC/AC inverter, the plant includes photovoltaic modules (PV modules) arranged in arrays connected to a respective DC/DC converters. A power collecting grid interfaces between the DC/DC converters and the DC/AC inverter. The method includes monitoring the performance of each PV array by adjusting the voltage level of each interface between a PV array and the corresponding DC/DC converter, and includes monitoring the output power of each DC/DC converter as a feedback for the regulating. | 12-24-2015 |